Erratum: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors (Journal of Cancer Research and Clinical Oncology; DOI 10.1007/s00432-009-0677-2);Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 1, 2010, Pages 165-167

  Oechsle, Karin ^a   Bokemeyer, Carsten ^a   Honecker, Friedemann ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cisplatin refractory; Germ cell tumor; Lenalidomide; Relapsed

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; LENALIDOMIDE; OXALIPLATIN; PACLITAXEL; TUMOR MARKER;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADULT; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; THALIDOMIDE; TREATMENT OUTCOME;

EID: 71449090387     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0697-y     Document Type: Erratum

References (10)

1. J Beyer D Kingreen M Krause, et al. 1997 Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy Cancer 79 161 168 10.1002/(SICI)1097-0142(19970101)79:1<161::AID-CNCR23>3. 0.CO;2-1 10.1002/(SICI)1097-0142(19970101)79:1<161::AID-CNCR23>3.0.CO;2-1 1:CAS:528:DyaK2sXmtVGhsA%3D%3D 8988741 (Pubitemid 26425522)
2. C Bokemeyer J Beyer B Metzner, et al. 1996 Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer Ann Oncol 7 31 34 1:STN:280:DyaK2s%2Fns12qtw%3D%3D 9081388
3. C Bokemeyer A Gerl P Schoffski, et al. 1999 Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer J Clin Oncol 17 512 516 1:CAS:528:DyaK1MXht1Wmurs%3D 10080593 (Pubitemid 29075236)
4. LH Einhorn 1999 Treatment of testicular cancer: a new and improved model J Clin Oncol 8 1777 1781
5. LH Einhorn MJ Stender SD Williams 1999 Phase II trial of gemcitabine in refractory germ cell tumors J Clin Oncol 17 509 511 1:CAS:528:DyaK1MXht1Wmuro%3D 10080592
6. K Fizazi S Culine I Chen 2004 Oxaliplatin in non-seminomatous germ-cell tumors Ann Oncol 15 1295 10.1093/annonc/mdh307 10.1093/annonc/mdh307 1:STN:280:DC%2BD2cznt1Wluw%3D%3D 15277272 (Pubitemid 39199319)
7. JT Hartmann L Kanz C Bokemeyer 1999 Diagnosis and treatment of patients with testicular germ cell cancer Drugs 58 257 281 10.2165/00003495-199958020- 00004 10.2165/00003495-199958020-00004 1:STN:280:DyaK1MzpvF2qug%3D%3D 10473019 (Pubitemid 29403266)
8. C Kollmannsberger O Rick H-G Derigs, et al. 2002 Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group J Clin Oncol 20 2031 2037 10.1200/JCO.2002.08.050 10.1200/JCO.2002.08.050 1:CAS:528:DC%2BD38XjvVKmsro%3D 11956262 (Pubitemid 34408792)
9. JC Miller LR Einhorn 1990 Phase II study of daily oral etoposide in refractory germ cell tumors Semin Oncol 17 36 39 1:STN:280:DyaK3c7mt1Shsw%3D%3D 2154858
10. O Rick T Braun W Siegert J Beyer 2006 Activity of thalidomide in patients with platinum-refractory germ-cell tumors Eur J Cancer 42 1775 1779 10.1016/j.ejca.2006.03.013 10.1016/j.ejca.2006.03.013 1:CAS:528: DC%2BD28XotFyltLg%3D 16765039 (Pubitemid 44164596)